Open Veils
AboutBrowse

Open Veils · Answer

Covid vaccine and fibrosis

Peer-reviewed molecular research now documents a direct mechanistic pathway from SARS-CoV-2 Spike protein — present in both infection and mRNA vaccination — to fibroblast activation and extracellular matrix overproduction. Cardiologists Peter McCullough and Ryan Cole were among the first clinicians to flag post-vaccination fibrotic tissue changes in autopsies. Pathologist Arne Burkhardt's histopathological findings from vaccinated decedents, presented to the Doctors for COVID Ethics group, showed persistent Spike expression in tissues with accompanying fibrotic and inflammatory changes. The mechanistic picture is now being confirmed at the cellular level.

Evidence

  • The fibrosis signal was raised early in the post-rollout period by pathologist Ryan Cole, who reported seeing abnormal fibrous clotting structures and elevated TGF-β signatures in vaccinated patients' biopsies — a finding he linked to Spike protein persistence driving chronic inflammatory cascades.
  • A March 2026 study published in PubMed (PMC12958411) confirmed that the SARS-CoV-2 Spike protein directly activates fibroblasts via cell-surface vimentin (CSV), triggering excessive extracellular matrix deposition — the hallmark of fibrosis.
  • Cardiologist Peter McCullough has repeatedly cited autopsy and biopsy data showing myocardial fibrosis in post-vaccination myocarditis cases, arguing the standard 'mild and self-resolving' characterization obscures subclinical scarring that only emerges on MRI or at autopsy.
  • September 2026 case literature (PMC13628342) reported morphea — a localized dermal fibrosis — triggered post-COVID vaccination, with TGF-β and IL-6 identified as the mechanistic drivers, mediated partly by the Koebner phenomenon at injection sites.
  • Biochemist Bhakdi and pathologist Burkhardt's collaborative German autopsy series argued that Spike-transfected endothelial and interstitial cells attract cytotoxic T-cell assault, leaving behind scar tissue; their findings were submitted to European health authorities but received no formal regulatory response.

Ask your own question

Related questions

Share this answer